Contact
searchSearch
HMP Global

Drug Recalls

The Latest

News
Olanzapine Tablets Recalled Due to Failed Impurities Specifications
10/01/2026
Rebecca Amrick
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a...
10/01/2026
Pharmacy Learning Network
News
Menow Sunscreen Pressed Powder Recalled Due to CGMP Deviations
10/01/2026
Rebecca Amrick
A voluntary Class II recall has been issued for Menow sunscreen pressed powder due to Current Good Manufacturing Practice (CGMP) deviations, a discrepancy that affects 2970 units.
A voluntary Class II recall has been issued for Menow sunscreen pressed powder due to Current Good Manufacturing Practice (CGMP) deviations, a discrepancy that affects 2970 units.
A voluntary Class II recall has...
10/01/2026
Pharmacy Learning Network
News
Exenatide Injection Recalled Due to Defective Delivery System
10/01/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for exenatide injection due to a defective drug delivery system, affecting 5694 pens.
The US Food and Drug Administration (FDA) has issued a Class II recall for exenatide injection due to a defective drug delivery system, affecting 5694 pens.
The US Food and Drug...
10/01/2026
Pharmacy Learning Network
News
Dopamine Hydrochloride Injection Recalled Due to Lack of Sterility Assurance
09/24/2026
Rebecca Amrick
Dopamine hydrochloride injection is under a voluntary Class II recall due to the product’s lack of sterility assurance.
Dopamine hydrochloride injection is under a voluntary Class II recall due to the product’s lack of sterility assurance.
Dopamine hydrochloride injection...
09/24/2026
Pharmacy Learning Network
News
Chlorthalidone Tablets Recalled Due to Failed Dissolution Specifications
09/24/2026
Rebecca Amrick
A voluntary Class II recall has been issued for chlorthalidone tablets after the product failed to meet dissolution specifications, a discrepancy that affects 13 567 bottles.
A voluntary Class II recall has been issued for chlorthalidone tablets after the product failed to meet dissolution specifications, a discrepancy that affects 13 567 bottles.
A voluntary Class II recall has...
09/24/2026
Pharmacy Learning Network
News
Thyroid Tablets Recalled Due to Drug Superpotency
09/24/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for thyroid tablets due to drug superpotency, affecting 1955 bottles.
The US Food and Drug Administration (FDA) has issued a Class I recall for thyroid tablets due to drug superpotency, affecting 1955 bottles.
The US Food and Drug...
09/24/2026
Pharmacy Learning Network
News
Povidone and Proparacaine Ophthalmic Solution Recalled Due to Drug Subpotency
09/17/2026
Rebecca Amrick
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine...
09/17/2026
Pharmacy Learning Network
News
Fluphenazine Hydrochloride Tablets Recalled Due to Failed Impurities Specifications
09/17/2026
Rebecca Amrick
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has...
09/17/2026
Pharmacy Learning Network
News
Dextrose Injection Recalled Due to the Presence of Stainless Steel Particles
09/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for dextrose injection due to the presence of stainless steel particles in the product, affecting 606 bags.
The US Food and Drug Administration (FDA) has issued a Class I recall for dextrose injection due to the presence of stainless steel particles in the product, affecting 606 bags.
The US Food and Drug...
09/17/2026
Pharmacy Learning Network
News
Topiramate Capsules Recalled Due to Failed Dissolution Specifications
09/10/2026
Rebecca Amrick
Trokendi (topiramate) extended-release capsules are under a voluntary Class III recall due to failed dissolution specifications, affecting 11 304 bottles.
Trokendi (topiramate) extended-release capsules are under a voluntary Class III recall due to failed dissolution specifications, affecting 11 304 bottles.
Trokendi (topiramate)...
09/10/2026
Pharmacy Learning Network
News
Trazodone Hydrochloride Tablets Recalled Due to the Presence of Foreign Tablets
09/10/2026
Rebecca Amrick
A voluntary Class II recall has been issued for trazodone hydrochloride tablets after the firm discovered foreign tablets in the product, a discrepancy that affects 175 392 bottles.
A voluntary Class II recall has been issued for trazodone hydrochloride tablets after the firm discovered foreign tablets in the product, a discrepancy that affects 175 392 bottles.
A voluntary Class II recall has...
09/10/2026
Pharmacy Learning Network

Newsfeed

News
Olanzapine Tablets Recalled Due to Failed Impurities Specifications
10/01/2026
Rebecca Amrick
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a...
10/01/2026
Pharmacy Learning Network
News
Menow Sunscreen Pressed Powder Recalled Due to CGMP Deviations
10/01/2026
Rebecca Amrick
A voluntary Class II recall has been issued for Menow sunscreen pressed powder due to Current Good Manufacturing Practice (CGMP) deviations, a discrepancy that affects 2970 units.
A voluntary Class II recall has been issued for Menow sunscreen pressed powder due to Current Good Manufacturing Practice (CGMP) deviations, a discrepancy that affects 2970 units.
A voluntary Class II recall has...
10/01/2026
Pharmacy Learning Network
News
Exenatide Injection Recalled Due to Defective Delivery System
10/01/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for exenatide injection due to a defective drug delivery system, affecting 5694 pens.
The US Food and Drug Administration (FDA) has issued a Class II recall for exenatide injection due to a defective drug delivery system, affecting 5694 pens.
The US Food and Drug...
10/01/2026
Pharmacy Learning Network
News
Dopamine Hydrochloride Injection Recalled Due to Lack of Sterility Assurance
09/24/2026
Rebecca Amrick
Dopamine hydrochloride injection is under a voluntary Class II recall due to the product’s lack of sterility assurance.
Dopamine hydrochloride injection is under a voluntary Class II recall due to the product’s lack of sterility assurance.
Dopamine hydrochloride injection...
09/24/2026
Pharmacy Learning Network
News
Chlorthalidone Tablets Recalled Due to Failed Dissolution Specifications
09/24/2026
Rebecca Amrick
A voluntary Class II recall has been issued for chlorthalidone tablets after the product failed to meet dissolution specifications, a discrepancy that affects 13 567 bottles.
A voluntary Class II recall has been issued for chlorthalidone tablets after the product failed to meet dissolution specifications, a discrepancy that affects 13 567 bottles.
A voluntary Class II recall has...
09/24/2026
Pharmacy Learning Network
News
Thyroid Tablets Recalled Due to Drug Superpotency
09/24/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for thyroid tablets due to drug superpotency, affecting 1955 bottles.
The US Food and Drug Administration (FDA) has issued a Class I recall for thyroid tablets due to drug superpotency, affecting 1955 bottles.
The US Food and Drug...
09/24/2026
Pharmacy Learning Network
News
Povidone and Proparacaine Ophthalmic Solution Recalled Due to Drug Subpotency
09/17/2026
Rebecca Amrick
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine...
09/17/2026
Pharmacy Learning Network
News
Fluphenazine Hydrochloride Tablets Recalled Due to Failed Impurities Specifications
09/17/2026
Rebecca Amrick
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has...
09/17/2026
Pharmacy Learning Network
News
Dextrose Injection Recalled Due to the Presence of Stainless Steel Particles
09/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for dextrose injection due to the presence of stainless steel particles in the product, affecting 606 bags.
The US Food and Drug Administration (FDA) has issued a Class I recall for dextrose injection due to the presence of stainless steel particles in the product, affecting 606 bags.
The US Food and Drug...
09/17/2026
Pharmacy Learning Network
News
Topiramate Capsules Recalled Due to Failed Dissolution Specifications
09/10/2026
Rebecca Amrick
Trokendi (topiramate) extended-release capsules are under a voluntary Class III recall due to failed dissolution specifications, affecting 11 304 bottles.
Trokendi (topiramate) extended-release capsules are under a voluntary Class III recall due to failed dissolution specifications, affecting 11 304 bottles.
Trokendi (topiramate)...
09/10/2026
Pharmacy Learning Network
News
Olanzapine Tablets Recalled Due to Failed Impurities Specifications
10/01/2026
Rebecca Amrick
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a...
10/01/2026
Pharmacy Learning Network
News
Menow Sunscreen Pressed Powder Recalled Due to CGMP Deviations
10/01/2026
Rebecca Amrick
A voluntary Class II recall has been issued for Menow sunscreen pressed powder due to Current Good Manufacturing Practice (CGMP) deviations, a discrepancy that affects 2970 units.
A voluntary Class II recall has been issued for Menow sunscreen pressed powder due to Current Good Manufacturing Practice (CGMP) deviations, a discrepancy that affects 2970 units.
A voluntary Class II recall has...
10/01/2026
Pharmacy Learning Network
News
Exenatide Injection Recalled Due to Defective Delivery System
10/01/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for exenatide injection due to a defective drug delivery system, affecting 5694 pens.
The US Food and Drug Administration (FDA) has issued a Class II recall for exenatide injection due to a defective drug delivery system, affecting 5694 pens.
The US Food and Drug...
10/01/2026
Pharmacy Learning Network
PharmLaw
Florida Attorney General Sues Insulin Manufacturers, PBMs Over Alleged Pricing Scheme
09/30/2026
Grace Taylor, MS, MA
Florida is challenging insulin manufacturer and pharmacy benefit manager (PBM) rebate and formulary arrangements that the state alleges contributed to higher insulin costs and restricted competition.
Florida is challenging insulin manufacturer and pharmacy benefit manager (PBM) rebate and formulary arrangements that the state alleges contributed to higher insulin costs and restricted competition.
Florida is challenging insulin...
09/30/2026
Pharmacy Learning Network
News
Dopamine Hydrochloride Injection Recalled Due to Lack of Sterility Assurance
09/24/2026
Rebecca Amrick
Dopamine hydrochloride injection is under a voluntary Class II recall due to the product’s lack of sterility assurance.
Dopamine hydrochloride injection is under a voluntary Class II recall due to the product’s lack of sterility assurance.
Dopamine hydrochloride injection...
09/24/2026
Pharmacy Learning Network
News
Chlorthalidone Tablets Recalled Due to Failed Dissolution Specifications
09/24/2026
Rebecca Amrick
A voluntary Class II recall has been issued for chlorthalidone tablets after the product failed to meet dissolution specifications, a discrepancy that affects 13 567 bottles.
A voluntary Class II recall has been issued for chlorthalidone tablets after the product failed to meet dissolution specifications, a discrepancy that affects 13 567 bottles.
A voluntary Class II recall has...
09/24/2026
Pharmacy Learning Network
News
Thyroid Tablets Recalled Due to Drug Superpotency
09/24/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for thyroid tablets due to drug superpotency, affecting 1955 bottles.
The US Food and Drug Administration (FDA) has issued a Class I recall for thyroid tablets due to drug superpotency, affecting 1955 bottles.
The US Food and Drug...
09/24/2026
Pharmacy Learning Network
PharmLaw
Express Scripts Faces Lawsuit Over Arkansas Pharmacy Reimbursement Rates
09/23/2026
Grace Taylor, MS, MA
Arkansas pharmacies allege Express Scripts violated state law by reimbursing prescription claims below required rates.
Arkansas pharmacies allege Express Scripts violated state law by reimbursing prescription claims below required rates.
Arkansas pharmacies allege...
09/23/2026
Pharmacy Learning Network
News
Povidone and Proparacaine Ophthalmic Solution Recalled Due to Drug Subpotency
09/17/2026
Rebecca Amrick
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine...
09/17/2026
Pharmacy Learning Network
News
Fluphenazine Hydrochloride Tablets Recalled Due to Failed Impurities Specifications
09/17/2026
Rebecca Amrick
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has...
09/17/2026
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use